Company intelligence / Profile preview

Matia Mobility

Salt Lake City, Utah, United Statesmatiamobility.com ↗

Ownership: Private
Development stage: Commercial

Overview

Matia Mobility has commercialized the Tek RMD M1, a robotic standing and mobility device for people with walking disabilities. The product has received CE Mark and two FDA 510(k) clearances and is now covered by insurance programs including Medicare and the VA. It enables users to independently transition between sitting and standing positions and navigate environments inaccessible to standard wheelchairs. The company’s focus remains on improving independence for individuals with mobility impairments.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (robotic mobility platform)
Industry: Assistive Medical Devices

Partnerships

Covered by U.S. Department of Veterans Affairsinsurance partnerships for reimbursement/coverage

Beyond the preview

Go deeper on Matia Mobility.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matia Mobility.

Explore the full profile